Buckland, please see inline:
"Anders just shows you do not read all the announcements, the CR was due to capital restructure which was one of the outcomes of the consolidation."
[Anders]: I read the announcements, there was nothing about a CR. A capital restructure does not equal CR
"It was not a total guess on my behalf, look at a number of companies that consolidate only then to issue more shares either in a CR or a issue of shares to so call special shareholders."
[Anders]: What number of companies do that?
"I would say something like 75% od stock go down once a consolidation has taken place unless there is some benefit out of the consolidation and for MOY there was none"
[Anders]: You are pulling that number out of thin air.
- Forums
- ASX - By Stock
- MOY
- market capital
market capital, page-67
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MOY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online